Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Prescription weight-loss medications carry serious risks, including a boxed warning for thyroid tumors, and are not appropriate for everyone
The framing throughout is published research observation these are research compounds studied in preclinical and clinical research, with one (tesamorelin/Egrifta) having pharmaceutical approval and the others operating in research peptide and (in CJC-1295's case) compounding pharmacy contexts
Always seek advice from a healthcare professional to choose the best course of action for your requirements
On the other, we risk medicalising thinness, increasing drug dependency, or diverting access from those most in need
We then create a personalized injection plan and administer the first dose during a follow-up visit or provide clear instructions for home dosing when appropriate
